Back to MILLENNIUM MANAGEMENT LLC MILLENNIUM MANAGEMENT LLC

BTAIQBTAIQ
4 quarters

Position history for MILLENNIUM MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC's holdings in BioXcel Therapeutics, Inc.

Yes. Millennium Management holds 2,114,710 shares of BTAIQ (BioXcel Therapeutics), worth $3M, as of its Q2 2026 13F filing. It increased the position by 177,950 shares (+9.2%) from Q1 2026. Millennium Management has held BTAIQ since Q3 2025, across 4 quarterly 13F filings.

Current Value

$3M

Current Shares

2.1M

Total Value Change

+$349,925

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+9.2%
$3M0.0%$1.41
29
2026-Q1
Increased
1.9M
+5.5%
$2.6M0.0%$1.34
28
2025-Q4
Increased
1.8M
+78.5%
$2.9M0.0%$1.60
40
2025-Q3
New
1M
-
$2.6M0.0%$2.56
36

Other major holders of BTAIQ: OAKTREE CAPITAL MANAGEMENT LP, VANGUARD CAPITAL MANAGEMENT LLC, FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used